PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31472402-4	2020	TB-KDM individuals exhibit significantly higher levels of IFNgamma, IL-2, TNFalpha, IL-17A, IL-1alpha, IL-1beta and IL-6 in comparison to TB-NDM, TB alone and DM alone individuals.	Terbium	0-2	interleukin 17A	Homo sapiens	84-90	
31472402-7	2020	TB-NDM individuals are also characterized by significantly diminished TB-antigen stimulated levels of IFNgamma, IL-2, TNFalpha, IL-17A, IL-17F, IL-1alpha, IL-1beta and/or IL-6 at pre-treatment and at 2  months of ATT and IFNgamma, IL-2, IL-1alpha and IL-1beta at post-treatment.	Terbium	0-2	interleukin 17A	Homo sapiens	128-134	
27746865-12	2016	The frequency of IL-17 producing CD4+ T cells in patients with active TB was lower than LTB subjects (P<0.05).	Terbium	70-72	interleukin 17A	Homo sapiens	17-22	
31024518-8	2019	Additionally, the frequency of IL-17-expressing CD4+ T cells, predominately with single-positive IL-17+ and double-positive IL-2+/IL-17+ phenotypes, was higher in participants with active TB than in the other two groups.	Terbium	188-190	interleukin 17A	Homo sapiens	31-36	
27746865-13	2016	CONCLUSION: The results of the present study might suggest that IL-17 and IL-23 play critical roles in the immune response against TB.	Terbium	131-133	interleukin 17A	Homo sapiens	64-69	
24993316-6	2014	At the present time whether a TB vaccine would work better if it targeted one specific T cell subset rather than another is as yet completely unknown, and this is now further complicated by new evidence that suggests other subsets such as IL-17 secreting CD4 T cells and cells with stem cell-like qualities may also play important roles.	Terbium	30-32	interleukin 17A	Homo sapiens	239-244	
27450011-7	2016	RESULTS: In comparing the differences significant differences in TB Ag tube response of IL-17 and IP-10, and "TB Ag - Nil" response of IL-10 and IP-10 were evident between the active TB and non-active TB groups.	Terbium	65-67	interleukin 17A	Homo sapiens	88-93	
26045845-1	2015	UNLABELLED: We conduct a case-control study to explore the possible association between IL-17 gene polymorphisms and development of TB.	Terbium	132-134	interleukin 17A	Homo sapiens	88-93	
27450011-8	2016	From the calculation of diagnostic performance for differentiating active TB patients from QFT-positive patients, among the measured values, the value of IL-17 TB Ag tube with the cut-off value set to <=0.82 (AUC 0.742) showed sensitivity, specificity, positive predictive value, and negative predictive value of 69.2%, 97.5%, 96.4%, and 76.5%, respectively.	Terbium	74-76	interleukin 17A	Homo sapiens	154-159	
27450011-9	2016	DISCUSSION: Among TB suspects, IL-17 TB Ag response had the highest ability to distinguish active TB followed by IP-10 TBAg-Nil response and the IL-17/IFN-gamma-TB Ag response combination improved the detection response.	Terbium	18-20	interleukin 17A	Homo sapiens	31-36	
27450011-9	2016	DISCUSSION: Among TB suspects, IL-17 TB Ag response had the highest ability to distinguish active TB followed by IP-10 TBAg-Nil response and the IL-17/IFN-gamma-TB Ag response combination improved the detection response.	Terbium	37-39	interleukin 17A	Homo sapiens	31-36	
27450011-9	2016	DISCUSSION: Among TB suspects, IL-17 TB Ag response had the highest ability to distinguish active TB followed by IP-10 TBAg-Nil response and the IL-17/IFN-gamma-TB Ag response combination improved the detection response.	Terbium	37-39	interleukin 17A	Homo sapiens	31-36	
27450011-10	2016	Differentiating active TB is best done using IL-17 as a biomarker, with IP-10 and IL-10 being potential useful.	Terbium	23-25	interleukin 17A	Homo sapiens	45-50	
22416258-11	2012	Taken together, the present findings suggest that analysis of the expansion of CD4(+)IFN-gamma(+)IL-17(+) T lymphocytes in peripheral blood of TB patients might be used as an indicator of the clinical outcome in active TB.	Terbium	143-145	interleukin 17A	Homo sapiens	97-102	
22338221-5	2011	The percentage of IL-17 before and after HAART were 1.90 +/- 0.9% vs. 4.65 +/- 1.48% respectively in HIV/TB group patients (P < 0.01).	Terbium	105-107	interleukin 17A	Homo sapiens	18-23